Procure Hemorrhoidal Ointment
NDC Package 55681-021-02
Package Information
Procure Hemorrhoidal (mineral oil, petrolatum, phenylephrine hcl) ointment is directionsAdults: when practical, cleanse the affected area by patting or blotting with an appropriate cleansing pad. This formulation utilizes a ointment delivery system. Marketed by Twin Med Llc, this product is identified by NDC 55681-021 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 1372298 - mineral oil 14 % / petrolatum 74.9 % / phenylephrine HCl 0.25 % Rectal Ointment
- RxCUI: 1372298 - mineral oil 0.14 MG/MG / petrolatum 0.749 MG/MG / phenylephrine hydrochloride 0.0025 MG/MG Rectal Ointment
- RxCUI: 1372298 - mineral oil 14 % / petrolatum 74.9 % / phenylephrine hydrochloride 0.25 % Rectal Ointment
Clinical Specifications
- Rectal - Administration to the rectum.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Regulatory & Marketing
Hierarchy Structure
- 55681 - Twin Med Llc
- 55681-021 - Procure Hemorrhoidal
- 55681-021-02 - 56.6 g in 1 TUBE, WITH APPLICATOR
- 55681-021 - Procure Hemorrhoidal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55681-021-02 identifies a specific commercial package of 56.6 g in 1 tube, with applicator of Procure Hemorrhoidal, a human over the counter drug labeled by Twin Med Llc. This ointment is formulated for rectal; topical use and contains mineral oil; petrolatum; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Twin Med Llc on June 16, 2025. The current certification is valid through December 31, 2026.
How is this Twin Med Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55681002102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.